Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial.
Uehara T, Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, Imamura T, Sakaguchi H, Fukushi A, Takeda Y, Baba K, Nobori H, Miyamoto T, Arita S, Dodo R, Shimba A, Fukao K, Shishido T, Tsuge Y, Mukae H.
Uehara T, et al.
Antiviral Res. 2025 Jan 30:106097. doi: 10.1016/j.antiviral.2025.106097. Online ahead of print.
Antiviral Res. 2025.
PMID: 39892563
Free article.